摘要 |
A compound of the formulawherein W is H or a beta-D-glucopyranoslyloxy group, and Y and Z are independently H, C1-6 alkyl, or C1-6 alkoxy or a pharmacologically acceptable derivative thereof, is effective in the treatment or prophylaxis of a disorder benefitting from a decrease in the activity or concentration of transaminase enzymes, particularly liver disorders. The compound is preferably administered orally as a dietary supplement in combination with one or more of bee pollen, matricaria camomile, asperula oderata, royal jelly or honey. |